Furthermore, p65 inhibition led to cancer stem cell enrichment in hormone receptor-positive/HER2-negative breast cancer cells, and this effect was mimicked by a STAT3 mutant deficient in the activation of p65 transcriptional activity [201]. This evidence concerns the gene RELA and breast carcinoma.